1-2 of 2
Leonardo Sahelijo, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Pharmacokinetics of the Complement Inhibitor TT30 in a Phase I Trial for Untreated PNH Patients

Antonio M Risitano, MD PhD, Michael Storek, Leonardo Sahelijo, MD, Mittie Doyle, Yang Dai, Ilene Ceil Weitz, MD, Judith C.W. Marsh, MD, Modupe Elebute, MBChB, MD, Casey L O'Connell, MD, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Giridharan Ramsingh, MD, Serena Marotta, MD, Andrzej Hellmann, Ante S. Lundberg, MD
Journal: Blood
Blood (2015) 126 (23): 2137.
https://doi.org/10.1182/blood.V126.23.2137.2137
Published: 2015
Journal Articles

First in Human Single-Ascending Dose Study: Safety, Biomarker, Pharmacokinetics and Exposure-Response Relationships of ALXN1210, a Humanized Monoclonal Antibody to C5, with Marked Half-Life Extension and Potential for Significantly Longer Dosing Intervals

Leonardo Sahelijo, MD, Arshad Mujeebuddin, MD, David Mitchell, PhD, Richard Larouche, MD, Zhao-Xue Yu, PhD, Yuchun Zhang, MD, Rekha Patel, Melissa Lasaro, PhD, Keith Bouchard, Bruce Andrien, PhD, Yi Wang, MD, Paul Tamburini, PhD, Susan Macdonald, PhD, Douglas Sheridan, PhD, Paresh Soni, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4777.
https://doi.org/10.1182/blood.V126.23.4777.4777
Published: 2015